Health Discovery Corporation Appoints Maher Albitar M.D., Former Medical Director of Hematology and Oncology and Chief of Research and Development at Quest Diagnostics Inc., Chief Medical Officer

SAVANNAH, Georgia--(BUSINESS WIRE)--Health Discovery Corporation (OTCBB: HDVY) (HDC) announced today the appointment of Maher Albitar, M.D., a world renowned cancer scientist and inventor, to the position of Chief Medical Officer. Until recently, Dr. Albitar was the Medical Director of Hematology and Oncology and Chief of Research and Development at Quest Diagnostics Nichols Institute (NYSE: DGX), San Juan Capistrano, Calif. Prior to Quest Diagnostics, Dr. Albitar was a tenured full professor at the M.D. Anderson Cancer Center and the University of Texas, where he served as chief of the hematopathology of the leukemia section with joint appointment in the clinical leukemia department.

MORE ON THIS TOPIC